Candida auris in US Correctional Facilities

被引:2
作者
Hennessee, Ian [1 ]
Forsberg, Kaitlin [1 ]
Erskine, Jalysa [2 ]
Charles, Argentina [2 ]
Russell, Barbara [2 ]
Reyes, Juliana [2 ]
Emery, Chantel [2 ]
Valencia, Nickolas [2 ]
Sherman, Adrienne [3 ]
Mehr, Jason [3 ]
Gallion, Hannah [4 ]
Halleck, Brandon [4 ]
Cox, Caleb [4 ]
Bryant, Marcie [4 ]
Nichols, Deborah [5 ]
Medrzycki, Magdalena [1 ]
Ham, D. Cal [1 ]
Hagan, Liesl M. [1 ]
Lyman, Meghan [1 ]
机构
[1] CDCP, 1600 Clifton Rd NE,Mailstop H24-10, Atlanta, GA 30329 USA
[2] Florida Dept Hlth, Tallahassee, FL USA
[3] New Jersey Dept Hlth, Trenton, NJ USA
[4] Indiana Dept Hlth, Indianapolis, IN USA
[5] Indiana Dept Correct, Indianapolis, IN USA
关键词
D O I
10.3201/eid3013.230860
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Candida auris is an emerging fungal pathogen that typically affects patients in healthcare settings. Data on C. auris cases in correctional facilities are limited but are needed to guide public health recommendations. We describe cases and challenges of providing care for 13 patients who were transferred to correctional facilities during January 2020- December 2022 after having a positive C. auris specimen. All patients had positive specimens identified while receiving inpatient care at healthcare facilities in geographic areas with high C. auris prevalence. Correctional facilities reported challenges managing patients and implementing prevention measures; those challenges varied by whether patients were housed in prison medical units or general population units. Although rarely reported, C. auris cases in persons who are incarcerated may occur, particularly in persons with known risk factors. Measures to manage cases and prevent C. auris spread in correctional facilities should address setting-specific challenges in healthcare and nonhealthcare correctional environments.
引用
收藏
页码:S36 / S40
页数:5
相关论文
共 17 条
  • [1] [Anonymous], 2012, Management of methicillin-resistant Staphylococcus aureus (MRSA) infections
  • [2] [Anonymous], 2020, Guidance on management of Coronavirus Disease 2019 (COVID-19) in correctional and detention facilities
  • [3] Infection control in jails and prisons
    Bick, Joseph A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) : 1047 - 1055
  • [4] Bureau of Justice Statistics, 2023, Impact of COVID-19 on state and federal prisons, March 2020-February2021
  • [5] Centers for Disease Control and Prevention, 2023, TRACKING CANDIDA AUR
  • [6] Centers for Disease Control and Prevention, 2022, Containment strategy: interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs)
  • [7] Centers for Disease Control and Prevention, 2022, Candida auris 2019 case definition
  • [8] Centers for Disease Control and Prevention, 2023, Implementation of personal protective equipment (PPE) use in nursing homes to prevent spread of multidrug-resistant organisms (MDROs)
  • [9] Centers for Disease Control and Prevention, 2021, National Survey of Prison Health Care
  • [10] Centers for Disease Control and Prevention, 2023, Infection control assessment and response (ICAR) tool for general infection prevention and control (IPC) across settings